Home > > > Report Detail

Global CRISPR/Cas9 Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Publisher Name :
Date: 26-Feb-2020
No. of pages: 127

Market Overview

The global CRISPR/Cas9 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The CRISPR/Cas9 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

CRISPR/Cas9 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, CRISPR/Cas9 market has been segmented into:

- Genome Editing

- Genetic engineering

- gRNA Database/Gene Librar

- CRISPR Plasmid

- Human Stem Cells

- Genetically Modified Organisms/Crops

- Cell Line Engineering

By Application, CRISPR/Cas9 has been segmented into:

- Biotechnology Companies

- Pharmaceutical Companies

- Academic Institutes

- Research and Development Institutes

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global CRISPR/Cas9 market presented in the report. This section sheds light on the sales growth of different regional and country-level CRISPR/Cas9 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global CRISPR/Cas9 market.

The report offers in-depth assessment of the growth and other aspects of the CRISPR/Cas9 market in important countries (regions), including:

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

- South America (Brazil, Argentina, Colombia)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and CRISPR/Cas9 Market Share Analysis

CRISPR/Cas9 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, CRISPR/Cas9 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the CRISPR/Cas9 sales, revenue and market share for each player covered in this report.

The major players covered in CRISPR/Cas9 are:

Caribou Biosciences

Thermo Fisher Scientific

Merck

Integrated DNA Technologies (IDT)

Takara Bio

CRISPR Therapeutics

Intellia Therapeutics

Editas Medicine

Mirus Bio

Horizon Discovery Group

Synthego

Agilent Technologies

GeneCopoeia

Cellecta

GenScript

Global CRISPR/Cas9 Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 CRISPR/Cas9 Market Overview
1.1 Product Overview and Scope of CRISPR/Cas9
1.2 Classification of CRISPR/Cas9 by Type
1.2.1 Global CRISPR/Cas9 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global CRISPR/Cas9 Revenue Market Share by Type in 2019
1.2.3 Genome Editing
1.2.4 Genetic engineering
1.2.5 gRNA Database/Gene Librar
1.2.6 CRISPR Plasmid
1.2.7 Human Stem Cells
1.2.8 Genetically Modified Organisms/Crops
1.2.9 Cell Line Engineering
1.3 Global CRISPR/Cas9 Market by Application
1.3.1 Overview: Global CRISPR/Cas9 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Global CRISPR/Cas9 Market by Regions
1.4.1 Global CRISPR/Cas9 Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of CRISPR/Cas9 (2015-2025)
1.4.3 North America (USA, Canada and Mexico) CRISPR/Cas9 Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) CRISPR/Cas9 Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CRISPR/Cas9 Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) CRISPR/Cas9 Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CRISPR/Cas9 Status and Prospect (2015-2025)
2 Company Profiles
2.1 Caribou Biosciences
2.1.1 Caribou Biosciences Details
2.1.2 Caribou Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Caribou Biosciences SWOT Analysis
2.1.4 Caribou Biosciences Product and Services
2.1.5 Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.4 Integrated DNA Technologies (IDT)
2.4.1 Integrated DNA Technologies (IDT) Details
2.4.2 Integrated DNA Technologies (IDT) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Integrated DNA Technologies (IDT) SWOT Analysis
2.4.4 Integrated DNA Technologies (IDT) Product and Services
2.4.5 Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takara Bio
2.5.1 Takara Bio Details
2.5.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takara Bio SWOT Analysis
2.5.4 Takara Bio Product and Services
2.5.5 Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.6 CRISPR Therapeutics
2.6.1 CRISPR Therapeutics Details
2.6.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 CRISPR Therapeutics SWOT Analysis
2.6.4 CRISPR Therapeutics Product and Services
2.6.5 CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.7 Intellia Therapeutics
2.7.1 Intellia Therapeutics Details
2.7.2 Intellia Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Intellia Therapeutics SWOT Analysis
2.7.4 Intellia Therapeutics Product and Services
2.7.5 Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.8 Editas Medicine
2.8.1 Editas Medicine Details
2.8.2 Editas Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Editas Medicine SWOT Analysis
2.8.4 Editas Medicine Product and Services
2.8.5 Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mirus Bio
2.9.1 Mirus Bio Details
2.9.2 Mirus Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mirus Bio SWOT Analysis
2.9.4 Mirus Bio Product and Services
2.9.5 Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.10 Horizon Discovery Group
2.10.1 Horizon Discovery Group Details
2.10.2 Horizon Discovery Group Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Horizon Discovery Group SWOT Analysis
2.10.4 Horizon Discovery Group Product and Services
2.10.5 Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.11 Synthego
2.11.1 Synthego Details
2.11.2 Synthego Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Synthego SWOT Analysis
2.11.4 Synthego Product and Services
2.11.5 Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.12 Agilent Technologies
2.12.1 Agilent Technologies Details
2.12.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Agilent Technologies SWOT Analysis
2.12.4 Agilent Technologies Product and Services
2.12.5 Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.13 GeneCopoeia
2.13.1 GeneCopoeia Details
2.13.2 GeneCopoeia Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GeneCopoeia SWOT Analysis
2.13.4 GeneCopoeia Product and Services
2.13.5 GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.14 Cellecta
2.14.1 Cellecta Details
2.14.2 Cellecta Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Cellecta SWOT Analysis
2.14.4 Cellecta Product and Services
2.14.5 Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
2.15 GenScript
2.15.1 GenScript Details
2.15.2 GenScript Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 GenScript SWOT Analysis
2.15.4 GenScript Product and Services
2.15.5 GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global CRISPR/Cas9 Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 CRISPR/Cas9 Players Market Share
3.2.2 Top 10 CRISPR/Cas9 Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global CRISPR/Cas9 Revenue and Market Share by Regions
4.2 North America CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
4.3 Europe CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
4.5 South America CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
5 North America CRISPR/Cas9 Revenue by Countries
5.1 North America CRISPR/Cas9 Revenue by Countries (2015-2020)
5.2 USA CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
5.3 Canada CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
5.4 Mexico CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
6 Europe CRISPR/Cas9 Revenue by Countries
6.1 Europe CRISPR/Cas9 Revenue by Countries (2015-2020)
6.2 Germany CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
6.3 UK CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
6.4 France CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
6.5 Russia CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
6.6 Italy CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
7 Asia-Pacific CRISPR/Cas9 Revenue by Countries
7.1 Asia-Pacific CRISPR/Cas9 Revenue by Countries (2015-2020)
7.2 China CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
7.3 Japan CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
7.4 Korea CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
7.5 India CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
8 South America CRISPR/Cas9 Revenue by Countries
8.1 South America CRISPR/Cas9 Revenue by Countries (2015-2020)
8.2 Brazil CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
8.3 Argentina CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue CRISPR/Cas9 by Countries
9.1 Middle East & Africa CRISPR/Cas9 Revenue by Countries (2015-2020)
9.2 Saudi Arabia CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
9.3 UAE CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
9.4 Egypt CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
9.5 South Africa CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global CRISPR/Cas9 Revenue and Market Share by Type (2015-2020)
10.2 Global CRISPR/Cas9 Market Forecast by Type (2019-2024)
10.3 Genome Editing Revenue Growth Rate (2015-2025)
10.4 Genetic engineering Revenue Growth Rate (2015-2025)
10.5 gRNA Database/Gene Librar Revenue Growth Rate (2015-2025)
10.6 CRISPR Plasmid Revenue Growth Rate (2015-2025)
10.7 Human Stem Cells Revenue Growth Rate (2015-2025)
10.8 Genetically Modified Organisms/Crops Revenue Growth Rate (2015-2025)
10.9 Cell Line Engineering Revenue Growth Rate (2015-2025)
11 Global CRISPR/Cas9 Market Segment by Application
11.1 Global CRISPR/Cas9 Revenue Market Share by Application (2015-2020)
11.2 CRISPR/Cas9 Market Forecast by Application (2019-2024)
11.3 Biotechnology Companies Revenue Growth (2015-2020)
11.4 Pharmaceutical Companies Revenue Growth (2015-2020)
11.5 Academic Institutes Revenue Growth (2015-2020)
11.6 Research and Development Institutes Revenue Growth (2015-2020)
12 Global CRISPR/Cas9 Market Size Forecast (2021-2025)
12.1 Global CRISPR/Cas9 Market Size Forecast (2021-2025)
12.2 Global CRISPR/Cas9 Market Forecast by Regions (2021-2025)
12.3 North America CRISPR/Cas9 Revenue Market Forecast (2021-2025)
12.4 Europe CRISPR/Cas9 Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific CRISPR/Cas9 Revenue Market Forecast (2021-2025)
12.6 South America CRISPR/Cas9 Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa CRISPR/Cas9 Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global CRISPR/Cas9 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of CRISPR/Cas9 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global CRISPR/Cas9 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market CRISPR/Cas9 Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Caribou Biosciences Corporate Information, Location and Competitors
Table 6. Caribou Biosciences CRISPR/Cas9 Major Business
Table 7. Caribou Biosciences CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 8. Caribou Biosciences SWOT Analysis
Table 9. Caribou Biosciences CRISPR/Cas9 Product and Solutions
Table 10. Caribou Biosciences CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 12. Thermo Fisher Scientific CRISPR/Cas9 Major Business
Table 13. Thermo Fisher Scientific CRISPR/Cas9 Total Revenue (USD Million) (2018-2019)
Table 14. Thermo Fisher Scientific SWOT Analysis
Table 15. Thermo Fisher Scientific CRISPR/Cas9 Product and Solutions
Table 16. Thermo Fisher Scientific CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck CRISPR/Cas9 Major Business
Table 19. Merck CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck CRISPR/Cas9 Product and Solutions
Table 22. Merck CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Integrated DNA Technologies (IDT) Corporate Information, Location and Competitors
Table 24. Integrated DNA Technologies (IDT) CRISPR/Cas9 Major Business
Table 25. Integrated DNA Technologies (IDT) CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 26. Integrated DNA Technologies (IDT) SWOT Analysis
Table 27. Integrated DNA Technologies (IDT) CRISPR/Cas9 Product and Solutions
Table 28. Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Takara Bio Corporate Information, Location and Competitors
Table 30. Takara Bio CRISPR/Cas9 Major Business
Table 31. Takara Bio CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 32. Takara Bio SWOT Analysis
Table 33. Takara Bio CRISPR/Cas9 Product and Solutions
Table 34. Takara Bio CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. CRISPR Therapeutics Corporate Information, Location and Competitors
Table 36. CRISPR Therapeutics CRISPR/Cas9 Major Business
Table 37. CRISPR Therapeutics CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 38. CRISPR Therapeutics SWOT Analysis
Table 39. CRISPR Therapeutics CRISPR/Cas9 Product and Solutions
Table 40. CRISPR Therapeutics CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Intellia Therapeutics Corporate Information, Location and Competitors
Table 42. Intellia Therapeutics CRISPR/Cas9 Major Business
Table 43. Intellia Therapeutics CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 44. Intellia Therapeutics SWOT Analysis
Table 45. Intellia Therapeutics CRISPR/Cas9 Product and Solutions
Table 46. Intellia Therapeutics CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Editas Medicine Corporate Information, Location and Competitors
Table 48. Editas Medicine CRISPR/Cas9 Major Business
Table 49. Editas Medicine CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 50. Editas Medicine SWOT Analysis
Table 51. Editas Medicine CRISPR/Cas9 Product and Solutions
Table 52. Editas Medicine CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Mirus Bio Corporate Information, Location and Competitors
Table 54. Mirus Bio CRISPR/Cas9 Major Business
Table 55. Mirus Bio CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 56. Mirus Bio SWOT Analysis
Table 57. Mirus Bio CRISPR/Cas9 Product and Solutions
Table 58. Mirus Bio CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Horizon Discovery Group Corporate Information, Location and Competitors
Table 60. Horizon Discovery Group CRISPR/Cas9 Major Business
Table 61. Horizon Discovery Group CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 62. Horizon Discovery Group SWOT Analysis
Table 63. Horizon Discovery Group CRISPR/Cas9 Product and Solutions
Table 64. Horizon Discovery Group CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Synthego Corporate Information, Location and Competitors
Table 66. Synthego CRISPR/Cas9 Major Business
Table 67. Synthego CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 68. Synthego SWOT Analysis
Table 69. Synthego CRISPR/Cas9 Product and Solutions
Table 70. Synthego CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Agilent Technologies Corporate Information, Location and Competitors
Table 72. Agilent Technologies CRISPR/Cas9 Major Business
Table 73. Agilent Technologies CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 74. Agilent Technologies SWOT Analysis
Table 75. Agilent Technologies CRISPR/Cas9 Product and Solutions
Table 76. Agilent Technologies CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. GeneCopoeia Corporate Information, Location and Competitors
Table 78. GeneCopoeia CRISPR/Cas9 Major Business
Table 79. GeneCopoeia CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 80. GeneCopoeia SWOT Analysis
Table 81. GeneCopoeia CRISPR/Cas9 Product and Solutions
Table 82. GeneCopoeia CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Cellecta Corporate Information, Location and Competitors
Table 84. Cellecta CRISPR/Cas9 Major Business
Table 85. Cellecta CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 86. Cellecta SWOT Analysis
Table 87. Cellecta CRISPR/Cas9 Product and Solutions
Table 88. Cellecta CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. GenScript Corporate Information, Location and Competitors
Table 90. GenScript CRISPR/Cas9 Major Business
Table 91. GenScript CRISPR/Cas9 Total Revenue (USD Million) (2017-2018)
Table 92. GenScript SWOT Analysis
Table 93. GenScript CRISPR/Cas9 Product and Solutions
Table 94. GenScript CRISPR/Cas9 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global CRISPR/Cas9 Revenue (Million USD) by Players (2015-2020)
Table 96. Global CRISPR/Cas9 Revenue Share by Players (2015-2020)
Table 97. Global CRISPR/Cas9 Revenue (Million USD) by Regions (2015-2020)
Table 98. Global CRISPR/Cas9 Revenue Market Share by Regions (2015-2020)
Table 99. North America CRISPR/Cas9 Revenue by Countries (2015-2020)
Table 100. North America CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Table 101. Europe CRISPR/Cas9 Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific CRISPR/Cas9 Revenue (Million USD) by Countries (2015-2020)
Table 103. South America CRISPR/Cas9 Revenue by Countries (2015-2020)
Table 104. South America CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa CRISPR/Cas9 Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Table 107. Global CRISPR/Cas9 Revenue (Million USD) by Type (2015-2020)
Table 108. Global CRISPR/Cas9 Revenue Share by Type (2015-2020)
Table 109. Global CRISPR/Cas9 Revenue Forecast by Type (2021-2025)
Table 110. Global CRISPR/Cas9 Revenue by Application (2015-2020)
Table 111. Global CRISPR/Cas9 Revenue Share by Application (2015-2020)
Table 112. Global CRISPR/Cas9 Revenue Forecast by Application (2021-2025)
Table 113. Global CRISPR/Cas9 Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. CRISPR/Cas9 Picture
Figure 2. Global CRISPR/Cas9 Revenue Market Share by Type in 2019
Figure 3. Genome Editing Picture
Figure 4. Genetic engineering Picture
Figure 5. gRNA Database/Gene Librar Picture
Figure 6. CRISPR Plasmid Picture
Figure 7. Human Stem Cells Picture
Figure 8. Genetically Modified Organisms/Crops Picture
Figure 9. Cell Line Engineering Picture
Figure 10. CRISPR/Cas9 Revenue Market Share by Application in 2019
Figure 11. Biotechnology Companies Picture
Figure 12. Pharmaceutical Companies Picture
Figure 13. Academic Institutes Picture
Figure 14. Research and Development Institutes Picture
Figure 15. Global CRISPR/Cas9 Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global CRISPR/Cas9 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global CRISPR/Cas9 Revenue Share by Players in 2019
Figure 23. Global Top 5 Players CRISPR/Cas9 Revenue Market Share in 2019
Figure 24. Global Top 10 Players CRISPR/Cas9 Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global CRISPR/Cas9 Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global CRISPR/Cas9 Revenue Market Share by Regions (2015-2020)
Figure 28. Global CRISPR/Cas9 Revenue Market Share by Regions in 2018
Figure 29. North America CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 30. Europe CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 32. South America CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 34. North America CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Figure 35. North America CRISPR/Cas9 Revenue Market Share by Countries in 2019
Figure 36. USA CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 37. Canada CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 38. Mexico CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 39. Europe CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Figure 40. Europe CRISPR/Cas9 Revenue Market Share by Countries in 2019
Figure 41. Germany CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 42. UK CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 43. France CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 44. Russia CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 45. Italy CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific CRISPR/Cas9 Revenue Market Share by Countries in 2019
Figure 48. China CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 49. Japan CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 50. Korea CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 51. India CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 53. South America CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Figure 54. South America CRISPR/Cas9 Revenue Market Share by Countries in 2019
Figure 55. Brazil CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 56. Argentina CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa CRISPR/Cas9 Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa CRISPR/Cas9 Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 60. UAE CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 61. Egypt CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 62. South Africa CRISPR/Cas9 Revenue and Growth Rate (2015-2020)
Figure 63. Global CRISPR/Cas9 Revenue Share by Type (2015-2020)
Figure 64. Global CRISPR/Cas9 Revenue Share by Type in 2019
Figure 65. Global CRISPR/Cas9 Market Share Forecast by Type (2021-2025)
Figure 66. Global Genome Editing Revenue Growth Rate (2015-2020)
Figure 67. Global Genetic engineering Revenue Growth Rate (2015-2020)
Figure 68. Global gRNA Database/Gene Librar Revenue Growth Rate (2015-2020)
Figure 69. Global CRISPR Plasmid Revenue Growth Rate (2015-2020)
Figure 70. Global Human Stem Cells Revenue Growth Rate (2015-2020)
Figure 71. Global Genetically Modified Organisms/Crops Revenue Growth Rate (2015-2020)
Figure 72. Global Cell Line Engineering Revenue Growth Rate (2015-2020)
Figure 73. Global CRISPR/Cas9 Revenue Share by Application (2015-2020)
Figure 74. Global CRISPR/Cas9 Revenue Share by Application in 2019
Figure 75. Global CRISPR/Cas9 Market Share Forecast by Application (2021-2025)
Figure 76. Global Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 77. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 78. Global Academic Institutes Revenue Growth Rate (2015-2020)
Figure 79. Global Research and Development Institutes Revenue Growth Rate (2015-2020)
Figure 80. Global CRISPR/Cas9 Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global CRISPR/Cas9 Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global CRISPR/Cas9 Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America CRISPR/Cas9 Revenue Market Forecast (2021-2025)
Figure 84. Europe CRISPR/Cas9 Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific CRISPR/Cas9 Revenue Market Forecast (2021-2025)
Figure 86. South America CRISPR/Cas9 Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa CRISPR/Cas9 Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs